Eagle Bay Advisors LLC Sells 22 Shares of Chemed Co. (NYSE:CHE)

Eagle Bay Advisors LLC trimmed its holdings in Chemed Co. (NYSE:CHE) by 10.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 183 shares of the company’s stock after selling 22 shares during the period. Eagle Bay Advisors LLC’s holdings in Chemed were worth $110,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Park Avenue Securities LLC acquired a new position in Chemed in the 1st quarter valued at about $213,000. Ballentine Partners LLC grew its position in shares of Chemed by 3.4% in the first quarter. Ballentine Partners LLC now owns 660 shares of the company’s stock valued at $424,000 after purchasing an additional 22 shares during the last quarter. Janiczek Wealth Management LLC increased its stake in shares of Chemed by 154.5% during the first quarter. Janiczek Wealth Management LLC now owns 196 shares of the company’s stock worth $126,000 after purchasing an additional 119 shares during the period. Wealth Enhancement Advisory Services LLC lifted its holdings in Chemed by 8.1% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 1,164 shares of the company’s stock worth $747,000 after purchasing an additional 87 shares during the last quarter. Finally, Thrive Wealth Management LLC bought a new stake in Chemed in the 1st quarter valued at $226,000. 95.85% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Chemed news, Director George J. Walsh III sold 200 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total transaction of $115,590.00. Following the completion of the transaction, the director now owns 3,446 shares in the company, valued at approximately $1,991,615.70. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, EVP Nicholas Michael Westfall sold 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total value of $1,123,160.00. Following the transaction, the executive vice president now owns 5,990 shares in the company, valued at $3,363,864.20. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director George J. Walsh III sold 200 shares of the company’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $577.95, for a total transaction of $115,590.00. Following the completion of the sale, the director now directly owns 3,446 shares of the company’s stock, valued at $1,991,615.70. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 9,144 shares of company stock worth $5,264,839 in the last 90 days. Insiders own 3.32% of the company’s stock.

Chemed Stock Down 0.4 %

Shares of Chemed stock traded down $2.18 during trading on Wednesday, reaching $591.38. The company’s stock had a trading volume of 5,105 shares, compared to its average volume of 83,256. Chemed Co. has a 52 week low of $502.64 and a 52 week high of $654.62. The firm has a market cap of $8.95 billion, a PE ratio of 31.95, a P/E/G ratio of 2.44 and a beta of 0.44. The business’s 50-day moving average price is $584.76 and its 200-day moving average price is $569.93.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing analysts’ consensus estimates of $5.59 by ($0.12). The company had revenue of $595.88 million during the quarter, compared to the consensus estimate of $599.20 million. Chemed had a return on equity of 29.21% and a net margin of 12.88%. The firm’s revenue for the quarter was up 7.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $4.71 EPS. Equities analysts predict that Chemed Co. will post 21.77 earnings per share for the current year.

Chemed Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 12th were issued a dividend of $0.50 per share. This is an increase from Chemed’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend was Monday, August 12th. This represents a $2.00 annualized dividend and a dividend yield of 0.34%. Chemed’s dividend payout ratio (DPR) is 10.76%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.